Economics at the FTC: Hospital Mergers,Authorized Generic Drugs,and Consumer Credit Markets期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Economics at the FTC: Hospital Mergers,Authorized Generic Drugs,and Consumer Credit Markets

Authors:	Joseph Farrell David J. Balan Keith Brand Brett W. Wendling

Affiliation:	(1) SantAnna School of Advanced Studies, Pisa, Italy;(2) DSA, Faculty of Economics, University of Florence, Via Montebello 7, 50123 Florence, Italy;(3) CERM, Center for the Economic Analysis of Competitiveness, Markets and Regulation, Via Banchi di Sotto 55, 53100 Siena, Italy;;

Abstract:	Economists at the Federal Trade Commission pursue the agency’s competition and consumer protection missions. In this year’s essay, in antitrust, we discuss various aspects of our hospital merger analyses as well as the effects of authorized generic drugs on consumers and competition. In consumer protection, we describe two ongoing studies on the use of credit-based insurance scores to price homeowners insurance, and the accuracy of consumers’ credit reports that are provided by credit bureaus.

Keywords:
本文献已被 SpringerLink 等数据库收录！